Nautilus Biotechnology, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Nautilus Biotechnology, Inc. (NAUT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $23.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-26
- Nautilus Biotechnology, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $23.00K.
- Nautilus Biotechnology, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2022 was $308.00K, a 165.52% increase from fiscal 2021.
- Nautilus Biotechnology, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2021 was $116.00K, a 48.67% decline from fiscal 2020.
- Nautilus Biotechnology, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2020 was $226.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | $23.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | $308.00K 10-K · filed 2023-02-23 |
| 2021-12-31 | $116.00K 10-K · filed 2023-02-23 |
| 2020-12-31 | $226.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |